What was the dollar value of contract 75A50120C00171?

The total obligated amount for contract 75A50120C00171 is $35,324,845.

When was contract 75A50120C00171 awarded?

Contract 75A50120C00171 was first awarded on September 25, 2020.

What NAICS code does contract 75A50120C00171 fall under?

Contract 75A50120C00171 is classified under NAICS code 541714.

What agency awarded contract 75A50120C00171?

Contract 75A50120C00171 was awarded by Department Of Health And Human Services.

Contract 75A50120C00171

Name: Contract 75A50120C00171 — federal award record
Creator: BesaGov
License: https://www.usa.gov/government-works

Invirsa, Inc. · Department Of Health And Human Services · September 25, 2020

Cost SharingFull & Open CompetitionNAICS 541714

Invirsa, Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 25, 2020 for $35.32 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Columbus, OH. It was awarded under full and open competition. The contract has been modified 11 times since the base award It uses cost sharing contract pricing. The most recent modification was on June 18, 2025.

Obligated to date

$35.32M

$35,324,845

Current value

$35.32M

Potential value

$37.51M

if all options exercised

Modifications

Latest June 18, 2025

Contract details

PIID: 75A50120C00171
Award type: Definitive Contract
Pricing: Cost Sharing
Set-aside: No Set Aside Used.
Competition: Full And Open Competition
NAICS: 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
Product / service: R&D- Other Research And Development (Advanced Development)
Place of performance: Columbus, OH
First action: September 25, 2020
Latest action: June 18, 2025

Description

INVIRSA - EXERCISE CLIN 0003/OPTION 2; UPDATE THE PERIOD OF PERFORMANCE (POP) FOR CLIN 0001, 0002, 0003 & 0004; UPDATE BUDGETS OF CLIN 0003 & 0004; UPDATE SOW; UPDATE FAR CLAUSES

Modification timeline

June 18, 2025

Mod P00011
INVIRSA - EXERCISE CLIN 0003/OPTION 2; UPDATE THE PERIOD OF PERFORMANCE (POP) FOR CLIN 0001, 0002, 0003 & 0004; UPDATE BUDGETS OF CLIN 0003 & 0004; UPDATE SOW;

$15.29M
July 17, 2024

Mod P00010
EO14042 INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3.

$1.98M
April 4, 2024

Mod P00009
EO14042 INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3.

$0
October 19, 2023

Mod P00008
EO14042 INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3.

$0
September 12, 2023

Mod P00007
EO14042 INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3.

$1.11M

May 5, 2023

Mod P00006
EO14042 INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3.

$0
April 7, 2023

Mod P00005
EO14042 INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3.

$0
January 5, 2023

Mod P00004
EO14042 INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3.

$0
August 1, 2022

Mod P00003
EO14042 INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3.

$0
November 30, 2021

Mod P00002
EO14042 INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3.

$0

Similar contracts

Recipient	Agency	Date	Obligated
Vericel Corporation	Department Of Health And Human Services	April 1, 2026	$34.88M
Ceramedix Holding, Llc	Department Of Health And Human Services	March 31, 2026	$4.22M
American College Of Medical Toxicology, Inc.	Department Of Health And Human Services	March 31, 2026	$0
Glaxosmithkline, Llc	Department Of Health And Human Services	March 31, 2026	$7.79M
Care Access Research Llc	Department Of Health And Human Services	March 31, 2026	$2.55M
Pattern Bioscience, Inc.	Department Of Health And Human Services	March 31, 2026	$22.50M

Top contractors in NAICS 541714

Lifetime obligated dollars across all federal contracts in this NAICS code.

#	Contractor	Contracts	Obligated
1	The Boeing Company	1	$4.44B
2	Advanced Technology International	9	$3.35B
3	Amgen USA Inc	2	$774.69M
4	Siga Technologies, Inc.	1	$624.44M
5	Icon Government And Public Health Solutions, Inc.	16	$404.80M
6	Technical Resources International, Inc.	19	$395.29M
7	Allucent Government Services (Us) Llc	9	$384.26M
8	Mapp Biopharmaceutical, Inc.	7	$354.24M
9	Ppd Development Lp	18	$331.02M
10	Albert B. Sabin Vaccine Institute, Inc. (The)	2	$305.87M

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

Helpful guides

Continue learning

See all guides →

Keep researching

Frequently asked questions

What is contract 75A50120C00171?

Contract 75A50120C00171 is a federal contract awarded to Invirsa, Inc. by Department Of Health And Human Services on September 25, 2020 for $35.32 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 11 times since the base award.

Who won contract 75A50120C00171?

Invirsa, Inc. won contract 75A50120C00171 from Department Of Health And Human Services.

How much is contract 75A50120C00171 worth?

Contract 75A50120C00171 has obligated $35.32 million to date, with a total potential value of $37.51 million if all options are exercised.